• Policy
• Alvogen receives approval for its Humira biosimilar in KOR
• by Lee, Hye-Kyung Oct 17, 2024 05:51am

• Opinion
• [Reporter’s View] Deadlines are set for a reason
• by Eo, Yun-Ho Oct 17, 2024 05:51am

• Product
• Wegovy's price varies by pharmacy in Korea
• by Jung, Heung-Jun Oct 17, 2024 05:51am

• Policy
• ‘Will raise ICER threshold for innovative new drugs’
• by Lee, Jeong-Hwan Oct 16, 2024 05:50am

• Opinion
• [Reporter's view] Expanding NIP to include 9-vHPV
• by Whang, byung-woo Oct 16, 2024 05:50am

• Policy
• Govt ‘is considering measures to overcome Korea Passing’
• by Lee, Jeong-Hwan Oct 16, 2024 05:50am

• Policy
• Stopping illegal online sales·advertisements of 'Wegovy'
• by Lee, Hye-Kyung Oct 16, 2024 05:50am

• InterView
• "JAK inhibitors bring a paradigm shift to RA treatment"
• by Whang, byung-woo Oct 16, 2024 05:50am

• Policy
• 'Will adjust the price of generic drugs through reevals'
• by Lee, Jeong-Hwan Oct 16, 2024 05:50am

• Policy
• Amgen starts negotiations to extend reimb of Kyprolis
• by Lee, Tak-Sun Oct 15, 2024 05:50am